" Table 7.8"
" Cancer of the Corpus and Uterus, NOS (Invasive)"
" 5-Year Relative and Period Survival by Race, Diagnosis Year, Age and Stage at Diagnosis"

" 5-Year Relative Survival (Percent) by Year of Diagnosis"
"Year of Diagnosis","All Races,All Ages","All Races,Ages <50","All Races,Ages 50+","Whites,All Ages","Whites,Ages <50","Whites,Ages 50+","Blacks,All Ages","Blacks,Ages <50","Blacks,Ages 50+"
"1960-1963(a)","-","-","-","73","-","-","31","-","-"
"1970-1973(a)","-","-","-","81","-","-","44","-","-"
"1975-1977(b)","86.9","92.7","86.2","88.0","93.3","87.4","60.0","84.4(g)","55.4"
"1978-1980(b)","82.5","91.7","81.3","83.7","93.1","82.6","54.9","82.3(g)","49.5"
"1981-1983(b)","80.7","91.2","79.4","82.2","92.3","81.1","50.7","82.8(g)","45.6"
"1984-1986(b)","82.4","93.6","81.0","84.0","93.9","82.8","56.2","83.5(g)","52.7"
"1987-1989(b)","82.3","89.8","81.2","83.9","90.9","83.0","56.7","82.8(g)","52.9"
"1990-1992(b)","83.7","90.1","82.7","85.8","92.2","84.8","54.0","72.9(g)","50.2"
"1993-1995(b)","83.2","90.0","82.0","84.9","91.5","83.8","58.5","81.7","53.9"
"1996-1998(b)","83.5","90.1","82.3","85.2","91.3","84.2","61.4","81.9","57.0"
"1999-2001(b)","84.2","88.7","83.3","85.9","89.9","85.2","61.4","70.9","58.8"
"2002-2005(b)","82.9","89.5","81.7","85.2","91.7","84.1","60.2","75.0","56.5"
"2006-2012(b)","83.4(f)","88.4(f)","82.5(f)","85.6(f)","89.8(f)","85.0(f)","65.7(f)","80.6","63.1(f)"


" 5-Year Period Survival (Percent)(c)(d)"
"Year","All Races,All Ages","All Races,Ages <50","All Races,Ages 50+","Whites,All Ages","Whites,Ages <50","Whites,Ages 50+","Blacks,All Ages","Blacks,Ages <50","Blacks,Ages 50+"
"2012","81.8","88.6","80.7","84.2","89.9","83.3","61.8","79.5","59.0"


" Stage Distribution (%) 2006-2012(c)(e), Case Counts and Percentages"
"Stage at Diagnosis","All Races,All Ages","All Races,Ages <50","All Races,Ages 50+","Whites,All Ages","Whites,Ages <50","Whites,Ages 50+","Blacks,All Ages","Blacks,Ages <50","Blacks,Ages 50+"
"Number of cases","71,625","10,498","61,127","57,838","7,890","49,948","7,158","978","6,180"
"Percent","100%","100%","100%","100%","100%","100%","100%","100%","100%"
"Localized","67","71","67","69","72","69","53","63","52"
"Regional","21","18","21","20","17","21","26","19","27"
"Distant","8","7","9","8","7","8","16","13","16"
"Unstaged","4","4","3","3","4","3","5","5","5"


" 5-Year Relative Survival (Percent) 2006-2012(c) by Age at Diagnosis"
"Age at Diagnosis","All Races,All Ages","All Races,Ages <50","All Races,Ages 50+","Whites,All Ages","Whites,Ages <50","Whites,Ages 50+","Blacks,All Ages","Blacks,Ages <50","Blacks,Ages 50+"
"Ages <45","89.1","-","-","90.0","-","-","81.1","-","-"
"Ages 45-54","87.8","-","-","89.6","-","-","70.7","-","-"
"Ages 55-64","84.5","-","-","87.0","-","-","64.6","-","-"
"Ages 65-74","78.3","-","-","81.4","-","-","57.8","-","-"
"Ages 75+","67.9","-","-","71.3","-","-","39.3","-","-"
"Ages <65","86.1","-","-","88.1","-","-","68.6","-","-"
"Ages 65+","74.3","-","-","77.4","-","-","52.0","-","-"


" 5-Year Relative Survival (Percent) 2006-2012(c) by Stage at Diagnosis(e)"
"Stage at Diagnosis","All Races,All Ages","All Races,Ages <50","All Races,Ages 50+","Whites,All Ages","Whites,Ages <50","Whites,Ages 50+","Blacks,All Ages","Blacks,Ages <50","Blacks,Ages 50+"
"All Stages","81.7","88.4","80.5","84.0","89.5","83.2","61.9","79.0","59.0"
"Localized","95.4","96.4","95.2","96.3","96.9","96.3","85.5","91.9","84.2"
"Regional","68.7","81.6","66.8","71.4","82.9","69.8","49.3","72.2","46.7"
"Distant","16.8","28.8","15.0","18.4","30.6","16.7","9.3","22.8","7.4"
"Unstaged","49.7","87.5","42.1","49.2","88.5","42.3","38.6","84.5(g)","30.8"



"(a)  Based on End Results data from a series of hospital registries and one population-based registry."
"(b)  SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).  Based on follow-up of patients into 2013."
"(c)  SEER 18 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey,  Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey and   Georgia excluding ATL/RG).  Based on follow-up of patients into 2013."
"(d)  Period survival provides a 2012 estimate of survival by piecing together the most recent conditional survival estimates  from several cohorts. It is computed here using three year calendar blocks (2010-2012: 0-1 year survival),  (2009-2011: 1-2 year survival), (2008-2010: 2-3 year survival), (2007-2009: 3-4 year survival), (2006-2008: 4-5 years survival)."
"(e)  Stage at diagnosis is classified using SEER Summary Stage 2000. Stage distribution percentages may not sum to 100 due to rounding."
"(f)  The difference between 1975-1977 and 2006-2012 is statistically significant (p<.05)."
"(g)  The standard error is between 5 and 10 percentage points."
"(h)  The standard error is greater than 10 percentage points."
"-  Statistic could not be calculated due to fewer than 25 cases during the time period."


Created by www.seer.cancer.gov/archive/csr/1975_2013/download_csr_datafile.php/sect_07_table.08.csv on 05/07/2026 6:40 am.